News
Published on: 26. August 2024

Pharma: UCB sells two divisions in China to international investors

pharma herstellung labor
Belgian pharmaceutical group UCB is selling two divisions of its China business to international investors. Neurology and Allergy are being sold for 680 million US dollars.

Sign up now and continue reading immediately

No credit card details required. No automatic renewal.

Sie haben bereits das Table.Briefing Abonnement?

Anmelden und weiterlesen
Last updated: 24. July 2025
Pharma
Share
Copied!